|
|
Axim Biotechnologies Inc (AXIM) |
|
|
|
Axim Biotechnologies Inc 's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
AXIM Annual EPS from Cont. Operations Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
Y / Y Annual EPS from Cont. Operations Change |
- |
- |
- |
- |
- |
Annual EPS from Cont. Operations (in $) |
$0.04 |
$-0.12 |
$-0.06 |
$-0.10 |
$-0.12 |
Annual EPS from Cont. Operations Growth
Comment |
In the fiscal year ended 2022, company achieved Annual EPS from Cont. Operations of $0.04 compare to EPS loss from Cont. Operations of $-0.12 realized a year before.
Axim Biotechnologies Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2022 Annual EPS from Cont. Operations | Biostax Corp | | | |